Who to recruit? Flaws? Nayeem: Companies wait too long to resource manufacturing side (COO). Details need clarity #BHCRForum17

10:16am April 20th 2017 via Hootsuite

Nayeem: If you are a scientist starting a company, remember your audience is different, have different goals, interests #BHCRForum17

10:15am April 20th 2017 via Hootsuite

Kohr: Start early, refine the story based on feedback. People will track you, and $8M investors were pitched 9mos earlier #BHCRForum17

10:12am April 20th 2017 via Hootsuite

Wu: Getting feedback for why an investor may not be interested "not a fit" but doesn't help entrepreneur at all. #BHCRForum17

10:09am April 20th 2017 via Hootsuite

Johnston: Some may get frustrated at investors, due to their focus on the market. Seek to understand why people say 'no' #BHCRForum17

10:08am April 20th 2017 via Hootsuite

Repositioning? Kohr: Retinopathy from a desktop to mobile. Kosofky: One cmpy went to the family office investors #BHCRForum17

10:05am April 20th 2017 via Hootsuite

Nayeem: Founded Vitesse in G-burg, although tech came out of Boston, due to experience of CEO #BHCRForum17

10:01am April 20th 2017 via Hootsuite

Nayeem: If mgmt in place. In Boston, Flagship, Third Rock will fill in management holes for a while. Unwilling to do elsewhere. #BHCRForum17

9:57am April 20th 2017 via Hootsuite

Kohr: At the Inst A level, do your homework on their focus, their story. Can get funding from overseas 'good ideas travel well' #BHCRForum17

9:56am April 20th 2017 via Hootsuite

Kosofsky: If the team and technology is there. Kohr: Hard at the shoestring/duct tape stage. Angel networks more geography #BHCRForum17

9:55am April 20th 2017 via Hootsuite

Johnston: You should be the best in these communities, and you will get funded. At seed stage, more sympathetic ($100K-200K) #BHCRForum17

9:54am April 20th 2017 via Hootsuite

Johnston: Have invested in MO, ID, NC. They invest there b/c 'we believe they are the best at what they do' #BHCRForum17

9:53am April 20th 2017 via Hootsuite

Staying in this region? Johnston: Doesn't believe that local VC isn't sufficient 'isn't an argument'. A national stage #BHCRForum17

9:52am April 20th 2017 via Hootsuite

Johnston: Many can get to senior people and borrow their expertise and credibility. Also may be great source of referrals #BHCRForum17

9:50am April 20th 2017 via Hootsuite

Nayeem: Others who have been successful don't tie themselves to a particular area; may need to talk with people all over #BHCRForum17

9:48am April 20th 2017 via Hootsuite

What's a new entrepreneur to do w/o experience? Nayeem: Founders may have a exec chairman who can recruit. Others network #BHCRForum17

9:47am April 20th 2017 via Hootsuite

Kosofsky: An A team could not get interest in a burn product; bought a small asset to reposition and move from there #BHCRForum17

9:45am April 20th 2017 via Hootsuite

Johnston: Da Vinci health for billing individuals. EVP didn't understand billing; so he did receivables in Boise ID for 1y #BHCRForum17

9:43am April 20th 2017 via Hootsuite

Kohr: You fix what can be fixed, and you want an A management team and a B business plan rather than the opposite #BHCRForum17

9:41am April 20th 2017 via Hootsuite

Early-stage startup input? Kohr: It's exciting, you see the holes. You see loans on buildings, need for restructuring #BHCRForum17

9:40am April 20th 2017 via Hootsuite

Wu: His big question is reimbursement: who will pay for your product? #BHCRForum17

9:39am April 20th 2017 via Hootsuite

Kosofsky: Looking at it from the debt side, does every role need a body? First 12-18 months, wearing multiple hats = good thing #BHCRForum17

9:39am April 20th 2017 via Hootsuite

Nayeem: You need to know the market size, what the market need and landscape is, and the clin trial design, costs #BHCRForum17

9:38am April 20th 2017 via Hootsuite

Kohr: What's the problem, how to you solve it, what's the revenue model? Be disciplined and focused on that #BHCRForum17

9:36am April 20th 2017 via Hootsuite

Kohr: Co's that at the first meeting it's the science or software (that's due diligence); take what you do and tell a story #BHCRForum17

9:36am April 20th 2017 via Hootsuite

Pet Peeve? Johnston: Series A, going to the moon. Series A is an experiment. You haven't figured it all out - makes me nervous #BHCRForum17

9:35am April 20th 2017 via Hootsuite

Panelists: Kristen Kosofsky (Hercules) Hook Johnson (Inova Strategic) Rick Kohr (Evergreen) Sara Nayeem (New Enterprise) #BHCRForum17

9:34am April 20th 2017 via Hootsuite

Raising Venture Capital Financing: how to succeed Bigly (Big League) #BHCRForum17 Moderator - Sam Wu Acuris Partners.

9:32am April 20th 2017 via Hootsuite

Will you be on the Mall on Sat? Van Hollen: The short answer is Yes. (applause) A very serious issue. #BHCRForum17

9:31am April 20th 2017 via Hootsuite

Messaging on SBIR funding (a % of NIH funding)? Van Hollen: Investments in R&D that cuts across agencies, agreed #BHCRForum17

9:11am April 20th 2017 via Hootsuite

SBIR admin pilot killed? Direct effect on NIH Entrepreneur in Residence Van Hollen: Happy to work on it #BHCRForum17

9:09am April 20th 2017 via Hootsuite

How to better present the value of life sci investment? Van Hollen: The work you do directly impacts people; powerful change #BHCRForum17

9:08am April 20th 2017 via Hootsuite

How to reduce barriers to collab regarding conflict of interest? Van Hollen: A case of the pendulum swinging too far. Will help #BHCRForum17

9:05am April 20th 2017 via Hootsuite

Longer-term biotech returns? Van Hollen: In software it can be so much shorter; it is harder for life sciences; stability impt #BHCRForum17

9:01am April 20th 2017 via Hootsuite

Van Hollen: Private/public partnerships: open to suggestions - federal incentives, academia, and private entities all together #BHCRForum17

8:59am April 20th 2017 via Hootsuite

Van Hollen: People can be brought in to help with the marketing part; would like to partner with that. #BHCRForum17

8:56am April 20th 2017 via Hootsuite

How to work better? Van Hollen: Progress is being made but it 'hasn't caught fire'. His youngest works at Instagram... #BHCRForum17

8:55am April 20th 2017 via Hootsuite

Van Hollen: From work done about the Olympics: perceptions of the DC area, politics have a spillover effect. #BHCRForum17

8:54am April 20th 2017 via Hootsuite

Regional working together? Van Hollen:One of his goals is exactly that- bringing regional resources together #BHCRForum17

8:52am April 20th 2017 via Hootsuite

Van Hollen: NIH, USM, Hopkins: through CRADAs and other methods - we need to maximize their potential. #BHCRForum17

8:50am April 20th 2017 via Hootsuite

Innovation in MD? Van Hollen:Hopkins and USM is where the innovation is; impt to emphasize STEM at the middle-school level #BHCRForum17

8:50am April 20th 2017 via Hootsuite

Van Hollen: Would have hoped to be in the 'expansion mode, not in a defensive one' regarding NIH budget #BHCRForum17

8:49am April 20th 2017 via Hootsuite

Van Hollen: @NIHDirector # of meritorious grants approved are declining; and the message it sends, keeps him up at night #BHCRForum17

8:48am April 20th 2017 via Hootsuite

Van Hollen: NIH purchasing power has eroded; bump to $32B; Cures Act passed. A 'bipartisan shock' to see a $6B cut to NIH #BHCRForum17

8:47am April 20th 2017 via Hootsuite

About the budget? @ChrisVanHollen Draconian cuts is not an overstatement. We need 'all hands on deck' for early-stg science #BHCRForum17

8:46am April 20th 2017 via Hootsuite

Van Hollen: Rule of 60% for legislation hasn't changed; more input, more opp for bipartisan cooperation #BHCRForum17

8:44am April 20th 2017 via Hootsuite

What about Jan 20th? Van Hollen: Moving from the House to the Senate: going from the 8th dist (home to NIH, FDA) to the state #BHCRForum17

8:44am April 20th 2017 via Hootsuite

Senator Chris Van Hollen (MD) and Mark Walsh (US SBA) at #BHCRForum17 https://t.co/wldLPZAbG9

8:42am April 20th 2017 via Hootsuite

Bahija Jallal EVP AstraZeneca with her opening remarks at #BHCRForum17 https://t.co/IU5Oxry6lY

8:39am April 20th 2017 via Hootsuite

Which Patients Will Be Helped By Immune Cancer Drugs? This Foundation Medicine Test May Tell | Forbes https://t.co/d83R2kiq5D #AACR17

8:10am April 20th 2017 via Hootsuite